Ginkgo Bioworks Holdings, Inc. (DNA)
6.80
+0.40
(+6.25%)
USD |
NYSE |
Mar 13, 16:00
6.82
+0.02
(+0.29%)
Pre-Market: 20:00
Ginkgo Bioworks Holdings EPS Diluted (Quarterly) : -1.456 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.024 |
| Zenas BioPharma, Inc. | -1.222 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | 1.944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -80.75M |
| Revenue (Quarterly) | 33.40M |
| Total Expenses (Quarterly) | 114.15M |
| Enterprise Value | 431.32M |
| Gross Profit Margin (Quarterly) | 51.30% |
| Profit Margin (Quarterly) | -241.8% |
| Earnings Yield | -83.58% |
| Normalized Earnings Yield | -83.84 |